Skip to main content
Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men
- Author(s): Glidden, David
- Grant, Robert
- Marcus, JL
- Glidden, DV
- McMahan, V
- Lama, JR
- Mayer, KH
- Liu, AY
- Montoya-Herrera, O
- Casapia, M
- Hoagland, B
- Grant, RM
- et al.
Published Web Location
http://europepmc.org/articles/PMC3956614?pdf=renderNo data is associated with this publication.
Abstract
Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.